Effect of Tamoxifen on the Enzymatic Activity of Human Cytochrome CYP2B6
- 1 June 2002
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 301 (3), 945-952
- https://doi.org/10.1124/jpet.301.3.945
Abstract
Tamoxifen is primarily used in the treatment of breast cancer. It has been approved as a chemopreventive agent for individuals at high risk for this disease. Tamoxifen is metabolized to a number of different products by cytochrome P450 enzymes. The effect of tamoxifen on the enzymatic activity of bacterially expressed human cytochrome CYP2B6 in a reconstituted system has been investigated. The 7-ethoxy-4-(trifluoromethyl)coumarin O-deethylation activity of purified CYP2B6 was inactivated by tamoxifen in a time- and concentration-dependent manner. Enzymatic activity was lost only in samples that were incubated with both tamoxifen and NADPH. The inactivation was characterized by a KI of 0.9 μM, a kinact of 0.02 min−1, and a t1/2 of 34 min. The loss in the 7-ethoxy-4-(trifluoromethyl)coumarinO-deethylation activity did not result in a similar percentage loss in the reduced carbon monoxide spectrum, suggesting that the heme moiety was not the major site of modification. The activity of CYP2B6 was not recovered after removal of free tamoxifen using spin column gel filtration. The loss in activity seemed to be due to a modification of the CYP2B6 and not reductase because adding fresh reductase back to the inactivated samples did not restore enzymatic activity. A reconstituted system containing purified CYP2B6, NADPH-reductase, and NADPH-generating system was found to catalyze tamoxifen metabolism to 4-OH-tamoxifen, 4′-OH-tamoxifen, andN-desmethyl-tamoxifen as analyzed by high-performance liquid chromatography analysis. Preliminary studies showed that tamoxifen had no effect on the activities of CYP1B1 and CYP3A4, whereas CYP2D6 and CYP2C9 exhibited a 25% loss in enzymatic activity.Keywords
This publication has 30 references indexed in Scilit:
- 4-Hydroxylated Metabolites of the Antiestrogens Tamoxifen and Toremifene Are Metabolized to Unusually Stable Quinone MethidesChemical Research in Toxicology, 1999
- THE ROLE OF CYP2B6 IN HUMAN XENOBIOTIC METABOLISM*Drug Metabolism Reviews, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Variable contribution of cytochromes p450 2d6, 2c9 and 3a4 to the 4-hydroxylation of tamoxifen by human liver microsomesBiochemical Pharmacology, 1997
- Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *JNCI Journal of the National Cancer Institute, 1994
- Expression of Modified Human Cytochrome P450 3A4 in Escherichia coli and Purification and Reconstitution of the EnzymeArchives of Biochemistry and Biophysics, 1993
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Metabolism of tamoxifen by isolated rat hepatocytes: anti-estrogenic activity of tamoxifen N-oxideBiochemical Pharmacology, 1982
- Rapid separation of low molecular weight solutes from liposomes without dilutionAnalytical Biochemistry, 1978
- The Metabolism of Tamoxifen (I.C.I. 46,474) Part I : In Laboratory AnimalsXenobiotica, 1973